These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9103037)

  • 1. [Study of anti-HIV activity of the yeast RNA-tilorone molecular complex].
    Karpov AV; Antonenko SV; Barbasheva EV; Spivak NIa
    Vopr Virusol; 1997; 42(1):17-9. PubMed ID: 9103037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the inhibiting effect of the molecular complex yeast RNA-tilorone on HIV-1 reproduction in vitro].
    Karpov AV; Antonenko SV; Barbasheva EV; Spivak NIa
    Biull Eksp Biol Med; 1998 Oct; 126(10):433-5. PubMed ID: 9825144
    [No Abstract]   [Full Text] [Related]  

  • 3. Virus-inhibitory effect of a yeast RNA-tilorone molecular complex in cell cultures.
    Karpov AV; Zholobak NM; Spivak NY; Rybalko SL; Antonenko SV; Krivokhatskaya LD
    Acta Virol; 2001 Jun; 45(3):181-4. PubMed ID: 11774897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiherpetic effect of RNA-tilorone molecular complex in cell culture].
    Skrots'ka OI; Zholobak NM; Antonenko SV; Spivak MIa; Karpov OV
    Mikrobiol Z; 2007; 69(3):62-8. PubMed ID: 17682533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Production of type I interferons in the body exposed to yeast RNA-tiloron molecular complexes].
    Karpov AV; Zholobak NM
    Vopr Virusol; 1996; 41(1):13-6. PubMed ID: 8669137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative cytotoxic characteristics of the interferon-inducing yeast RNA-tilorone complex].
    Zholobak NM; Karpov AV; Rybalko SL; Antonenko SV; Barbasheva EV
    Antibiot Khimioter; 1999; 44(4):21-4. PubMed ID: 10483492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferonogenic activity of immobilized ribopolynucleotides in vitro].
    Zholobak NM; Mandzhos AP; Verevka SV; Povodzinskiĭ VM; Karpov AV
    Ukr Biokhim Zh (1999); 2003; 75(6):106-10. PubMed ID: 15143526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The inhibiting action of interferon inducers on the multiplication of the human immunodeficiency virus].
    Nosik NN; Nosik DN; Kuznetsova NV
    Vopr Virusol; 1992; 37(2):92-4. PubMed ID: 1441434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The interferonogenic properties of yeast RNA-tilorone complexes in a cell culture].
    Karpov AV; Zholobak NM
    Antibiot Khimioter; 1995 May; 40(5):20-3. PubMed ID: 8534174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HIV-1 effect of compound K3 from flower of Japanese pagoda tree in vitro].
    Zhang GH; Zheng YT
    Zhong Yao Cai; 2006 Apr; 29(4):355-8. PubMed ID: 16913492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The depression of the reproduction of the human immunodeficiency virus by the use of Bogomolets antireticular cytotoxic serum].
    Spivak MIa; Karpov OV; Antonenko SV; Barbasheva OV; Kvielienkova KI; Voloshchenko IuV
    Mikrobiol Z; 1997; 59(5):57-61. PubMed ID: 9480019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of interferonogenic molecular complex of yeast RNA--tilorone on DNA, RNA and protein synthesis in vitro].
    Karpov OV; Antonenko SV; Barbasheva OV; Kravchenko OM; Kysel'ova OK; Tkachikova L
    Ukr Biokhim Zh (1999); 2001; 73(2):33-8. PubMed ID: 11642041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs.
    Gláz ET; Tálas M
    Arch Virol; 1975; 48(4):375-84. PubMed ID: 1200845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between antiinflammatory action of tilorone and its interferon inducing activity.
    Hiyama Y; Kuriyama K
    Agents Actions; 1991 Jul; 33(3-4):229-32. PubMed ID: 1719782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
    Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the enzymic activity of monooxygenase components of rat hepatocytes after administration of tilorone].
    Bogatskiĭ AV; Galkin VN; Golovenko NIa; Filippova TO; Litvinova LA
    Ukr Biokhim Zh (1978); 1981; 53(6):108-10. PubMed ID: 7324184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of interferon inducers on chemically-induced mutagenesis and carcinogenesis].
    Loginova NS; Kinzirskiĭ AS; Parshina OV; Mirskaia EE; Ershov FI
    Vestn Ross Akad Med Nauk; 1996; (3):28-33. PubMed ID: 8672957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferonogenic and antiviral activity of the tobacco mosaic virus, tilorone and sodium nucleinate].
    Balezina TI; Fadeeva LL; Zemskov VM; Korneeva LE; Loĭdina GI
    Antibiotiki; 1976 Mar; 21(3):250-4. PubMed ID: 818948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents].
    Pokrovskiĭ AG; Pliasunova OA; Gashnikova NM; Mamaeva OA; Fediuk NV
    Vopr Virusol; 2001; 46(6):38-42. PubMed ID: 11785387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.